论文部分内容阅读
美国勃利斯多—迈耶公司(Bristol—Myers Company)的勃利斯多实验所最近制成一种新的抗菌素制剂,且已取得食品药物管理处的批准,目前先作为淋病的口服治疗药出售。对其他疾病的治疗作用尚在进一步研究中。
The Bristol-Myers Company’s Bristol-Myers Company recently completed a new antibiotic preparation that has been approved by the Food and Drug Administration and is currently used as an oral treatment for gonorrhea sell. The treatment of other diseases is still under study.